94 related articles for article (PubMed ID: 16643889)
1. Effects of adenosine A(3) receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice.
Hofer M; Pospísil M; Vacek A; Holá J; Znojil V; Weiterová L; Streitová D
Eur J Pharmacol; 2006 May; 538(1-3):163-7. PubMed ID: 16643889
[TBL] [Abstract][Full Text] [Related]
2. Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells.
Hofer M; Pospísil M; Znojil V; Holá J; Streitová D; Vacek A
Exp Biol Med (Maywood); 2008 Jul; 233(7):897-900. PubMed ID: 18445770
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A(3) receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis.
Hofer M; Pospísil M; Znojil V; Holá J; Vacek A; Streitová D
Biomed Pharmacother; 2007 Jul; 61(6):356-9. PubMed ID: 17383145
[TBL] [Abstract][Full Text] [Related]
4. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
[TBL] [Abstract][Full Text] [Related]
5. N6-cyclopentyladenosine inhibits proliferation of murine haematopoietic progenitor cells in vivo.
Pospísil M; Hofer M; Vacek A; Holá J; Pipalová I; Znojil V
Eur J Pharmacol; 2005 Jan; 507(1-3):1-6. PubMed ID: 15659287
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P; Dolezel P
Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
[TBL] [Abstract][Full Text] [Related]
7. IB-MECA and cardioprotection.
Xu Z; Jang Y; Mueller RA; Norfleet EA
Cardiovasc Drug Rev; 2006; 24(3-4):227-38. PubMed ID: 17214599
[TBL] [Abstract][Full Text] [Related]
8. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
Panjehpour M; Karami-Tehrani F
Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
Yuan K; Bai GY; Park WH; Kim SZ; Kim SH
Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
[TBL] [Abstract][Full Text] [Related]
12. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil.
Pospísil M; Hofer M; Vacek A; Znojil V; Pipalová I
Physiol Res; 2004; 53(5):549-56. PubMed ID: 15479134
[TBL] [Abstract][Full Text] [Related]
13. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training.
Priviero F; De Nucci G; Antunes E; Zanesco A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918
[TBL] [Abstract][Full Text] [Related]
14. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes.
Wittendorp MC; Boddeke HW; Biber K
Glia; 2004 May; 46(4):410-8. PubMed ID: 15095371
[TBL] [Abstract][Full Text] [Related]
16. Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.
Djazayeri K; Szilvássy Z; Peitl B; Németh J; Nagy L; Kiss A; Szabó B; Benko I
Eur J Pharmacol; 2005 Oct; 522(1-3):122-9. PubMed ID: 16213483
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart.
Hochhauser E; Leshem D; Kaminski O; Cheporko Y; Vidne BA; Shainberg A
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):363-8. PubMed ID: 17669867
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage.
Emanuelov AK; Shainberg A; Chepurko Y; Kaplan D; Sagie A; Porat E; Arad M; Hochhauser E
Biochem Pharmacol; 2010 Jan; 79(2):180-7. PubMed ID: 19686702
[TBL] [Abstract][Full Text] [Related]
19. IB-MECA, an adenosine A(3) receptor agonist, does not influence survival of lethally γ-irradiated mice.
Hofer M; Pospíšil M; Dušek L; Hoferová Z; Komůrková D
Physiol Res; 2012; 61(6):649-54. PubMed ID: 23098658
[TBL] [Abstract][Full Text] [Related]
20. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
